A easy blood check would possibly assist predict a girl’s threat of dementia as much as 25 years earlier than any signs begin, a brand new examine suggests.
The blood check seems to be for elevated ranges of a protein generally known as phosphorylated tau 217 (p-tau217) that may reveal mind plaques tied to Alzheimer’s illness, the most typical explanation for dementia.
For the examine, researchers examined for this protein in blood samples supplied by about 2,800 cognitively wholesome girls ages 65 to 79. Over a follow-up interval of as much as 25 years, simply over 1,300 of the ladies developed dementia or delicate cognitive impairment, a possible precursor to dementia.
“Our examine suggests we could possibly establish girls at elevated threat for dementia many years earlier than signs emerge,” says the lead examine creator, Aladdin Shadyab, PhD, MPH, an affiliate professor of public well being and medication on the College of California in San Diego.
“That type of lengthy lead time opens the door to earlier prevention methods and extra focused monitoring, quite than ready till reminiscence issues are already affecting every day life,” Dr. Shadyab says.
Blood Checks Have been Higher Predictors of Danger for Sure Folks
The examine means that not all girls have the identical threat of delicate cognitive impairment or dementia based mostly on elevated ranges of p-tau217 of their blood.
Greater ranges of this protein had been extra strongly linked to poorer cognitive outcomes in girls over 70 years outdated than in youthful examine contributors. Elevated protein ranges had been additionally a greater predictor of dementia threat in girls who had a genetic predisposition for Alzheimer’s than in girls with out a genetic threat issue.
As well as, larger protein ranges within the blood had been a stronger predictor of dementia threat in girls who took hormone remedy for menopause combining each estrogen and progestin than in girls who didn’t use hormones.
However the examine wasn’t designed to find out whether or not or how hormone remedy use would possibly straight influence ranges of p-tau217 within the blood or dementia threat, Shadyab says. Extra analysis is required on this space.
Danger With Hormone Remedy
It’s vital to notice that the upper threat of cognitive decline related to hormone remedy on this examine was present in girls who began hormones after age 65, says JoAnn Manson, MD, MPH, DrPH, a professor at Harvard Medical Faculty and the chief of preventive medication at Brigham and Ladies’s Hospital in Boston.
“This threat wouldn’t be anticipated amongst girls beginning estrogen remedy early in menopause,” Dr. Manson says. “Prior analysis suggests a impartial or useful impact of hormone remedy on cognition in youthful girls.”
Blood Check Might Be ‘Sport-Altering’ in Predicting Dementia Danger
Shadyab says blood-based biomarker exams are much less invasive and extra exact than different methods of figuring out dementia threat, resembling spinal faucets or mind scans. Whereas they’re not prepared for use for screening simply but — they aren’t accredited or really helpful for youthful folks or people who’re symptom-free — Manson says the newest outcomes are promising.
“This is without doubt one of the largest research to display that p-tau217 blood ranges can efficiently predict future threat of cognitive impairment and dementia,” Manson says. “The supply and accessibility of this easy blood check can be game-changing on this discipline.”
